Stomach size reduction for weight loss in people with heart failure
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty, which uses an endoscope (a flexible tube with a camera) to reduce the size of your stomach, helping you eat less and lose weight. It is designed for people who have both obesity and a type of heart failure called HFpEF (heart failure with preserved ejection fraction), and aims to improve heart symptoms and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be between 30 and 50.
- You must have a heart failure diagnosis with a specific type called HFpEF (heart failure with preserved ejection fraction).
- You must not have had any previous weight-loss surgery.
- You must be willing to stop taking any weight-loss medications during the study.
- You must be able to walk at least 100 meters in a 6-minute walk test.
- You must be stable on your current medications, with no changes to diabetes medications for the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a procedure called endoscopic sleeve gastroplasty, which uses a device to reduce the size of your stomach without surgery. It aims to see if this helps improve blood sugar control and weight in adults with type 2 diabetes and obesity.
This trial tests a non-surgical procedure called Endoscopic Sleeve Gastroplasty (ESG) to help people with obesity lose weight. A doctor uses a thin tube with a camera to stitch your stomach smaller, so you feel full sooner.
This study tests a new procedure called endoscopic sleeve gastroplasty with fundal mucosal ablation to help with weight loss. It is an option for people with obesity who have not had success with other methods and who have not had prior stomach surgery.
This trial tests an endoscopic procedure that helps reduce stomach size to support weight loss in people with severe kidney disease who may need a kidney transplant. It may help some patients meet transplant-center weight requirements and potentially improve readiness for transplant care.
This trial tests a procedure called Endoscopic Sleeve Gastroplasty (ESG) as a non-surgical option for weight loss. It aims to help people who have not been able to lose weight with diet and exercise, and who either cannot or prefer not to have bariatric surgery.
This study tests a weight-loss procedure called endoscopic sleeve gastroplasty (a stomach-reducing procedure done through a scope) in people with both obesity and inflammatory bowel disease (IBD). It aims to see if the procedure is safe and helpful for this group.
Hear when a new Obesity (BMI>30) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.